In colorectal cancer (CRC) tissues and cell lines [30, 33], sebaceous gland carcinoma [34], neuroblastomas [35], bladder cancer tissues [36] and prostate cancer cells [37], sestrin 2 was downregulated in comparison with related non-cancerous tissues and cells. This evidence concerns the gene SESN2 and urinary bladder carcinoma.